Meetings

  • The Potential Role of Nutrition in the First 2 Years of Life in the Prevention of Child Overweight and Obesity: A Webinar Date: July 18, 2019 (12:00 PM Eastern)

    This virtual workshop will explore the role of infant and early childhood nutrition (birth to <2 years of age) related to healthy growth and the prevention of overweight and obesity later in childhood.
  • The Role of NIH in Drug Development Innovation and its Impact on Patient Access: A Workshop Date: July 24, 2019 - July 25, 2019 (8:00 AM Eastern)

    An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access.
  • Future of Nursing 2030: Philadelphia Town Hall Date: July 24, 2019 (8:30 AM Eastern)

    The Committee on the Future of Nursing 2020-2030 would like to hear your insights on ways to advance the nursing profession to help our nation create a culture of health, reduce health disparities, and improve the health and well-being of the U.S. population in the 21st century.
  • Future of Nursing 2030: Seattle Town Hall Date: August 7, 2019 (8:30 AM Pacific)

    The Committee on the Future of Nursing 2020-2030 would like to hear your insights on ways to advance the nursing profession to help our nation create a culture of health, reduce health disparities, and improve the health and well-being of the U.S. population in the 21st century.
  • Fourth Meeting of the Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment Date: August 21, 2019 - August 22, 2019 (8:30 AM Eastern)
    Committee Only
    Fourth Meeting of the Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment
  • Enhancing Scientific Reproducibility through Transparent Reporting – A Workshop Date: September 25, 2019 - September 26, 2019 (8:30 AM Eastern)

    An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (National Academies) will plan and conduct a one-day public workshop to explore issues related to transparent reporting (e.g. disclosure of the availability and location of data, materials, analysis, and methodology) to improve rigor and reproducibility in biomedical research.
  • Exploring Key Policy Challenges and Opportunities to Improve Care for People with Mental Health and Substance Use Disorders: A Workshop Date: October 15, 2019 (8:00 AM Eastern)

    The first workshop of the Forum on Mental Health and Substance Use Disorders.
  • Applying Big Data to Address the Social Determinants of Health in Oncology: A Workshop Date: October 28, 2019 - October 29, 2019 (8:00 AM Eastern)

    The collection and analysis of big data is expected to transform the field of cancer research and improve cancer care. Innovations in analytic methods, coupled with large-scale efforts to collect big data, are advancing progress in precision medicine initiatives and facilitating research on factors that influence cancer incidence and outcomes.
  • Understanding and Responding to Global Health Security Risks from Microbial Threats in the Arctic: A Workshop Date: November 6, 2019 - November 7, 2019 (12:00 AM GMT+2)

    This workshop will bring together an international, interdisciplinary group of experts to explore what is known, and what critical knowledge gaps remain, regarding existing and possible future risks of harmful infectious agents emerging from thawing Arctic environments
  • Exploring Novel Clinical Trial Designs for Gene-Based Therapies – A Workshop Date: November 13, 2019 (8:30 AM Eastern)

    Designing clinical trials to test the safety and efficacy of regenerative medicine therapies, such as gene- and gene-editing- based therapies, can be complex for several reasons including challenges with determining an optimal dosage, delivering the product effectively, and successfully recruiting patients, to name a few. Patients and clinicians may also face difficult decisions about enrollment in a gene therapy or trial in certain instances where the trial is considered to offer a “single chance,” possibly making the patients ineligible for future trials. To further explore the design complexities and ethical issues associated with clinical trials for these types of therapies, the Forum on Regenerative Medicine will hold a one-day workshop in Washington, DC on November 13, 2019. Speakers at the workshop may be asked to discuss patient recruitment and selection for gene-based clinical trials, assessing the safety of new therapies, dose escalation, and ethical issues such as informed consent and the role of clinicians in recommending trials as options to their patients.